关键词：生物技术；生物制药；亚太市场
摘 要：The Asia-Pacific biotech industry continued its strong performance in the second half of 2013,remaining one of the fastest emerging industries regionally and globally.Several leading companies reported higher revenues, while an average of the stock prices of companies tracked by Mergent rose 12.54% over the six-month period. Due to economic challenges in several major markets, a steady number of foreign biotech and pharmaceutical companies, particularly from North America and Europe, shifted their focus to markets in the Asia-Pacific.The industry also saw several cross-border mergers and acquisitions (M&A) as biotech companies sought to obtain the benefits of various fiscal incentives in other nations and regions.